HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 280, Issue 39, 33324-33330, September 30, 2005

This Article Abstract Full Text (PDF) All Versions of this Article: 280/39/33324    most recent M506500200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tamayo, R. Articles by Camilli, A. Search for Related Content PubMed PubMed Citation Articles by Tamayo, R. Articles by Camilli, A. Social Bookmarking                      What's this?

The EAL Domain Protein VieA Is a Cyclic Diguanylate Phosphodiesterase^*

Rita Tamayo, Anna D. Tischler, and Andrew Camilli, An investigator of the Howard Hughes Medical Institute.1

From the Howard Hughes Medical Institute and Tufts University School of Medicine and the Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts 02111

Received for publication, June 15, 2005 , and in revised form, July 27, 2005.

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
The newly recognized bacterial second messenger 3',5'-cyclic diguanylic acid (cyclic diguanylate (c-di-GMP)) has been shown to regulate a wide variety of bacterial behaviors and traits. Biosynthesis and degradation of c-di-GMP have been attributed to the GGDEF and EAL protein domains, respectively, based primarily on genetic evidence. Whereas the GGDEF domain was demonstrated to possess diguanylate cyclase activity in vitro, the EAL domain has not been tested directly for c-di-GMP phosphodiesterase activity. This study describes the analysis of c-di-GMP hydrolysis by an EAL domain protein in a purified system. The Vibrio cholerae EAL domain protein VieA has been shown to inversely regulate biofilm-specific genes (vps) and virulence genes (ctxA), presumably by decreasing the cellular pool of c-di-GMP. VieA was maximally active at neutral pH, physiological ionic strength, and ambient temperatures and demonstrated c-di-GMP hydrolytic activity with a K_m of 0.06 µM. VieA was unable to hydrolyze cGMP. The putative metal coordination site of the EAL domain, Glu¹⁷⁰, was demonstrated to be necessary for VieA activity. Furthermore, the divalent cations Mg²⁺ and Mn²⁺ were necessary for VieA activity; conversely, Ca²⁺ and Zn²⁺ were potent inhibitors of the VieA phosphodiesterase. Calcium inhibition of the VieA EAL domain provides a potential mechanism for regulation of c-di-GMP degradation.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
The cyclic dinucleotide 3',5'-cyclic diguanylic acid (c-di-GMP)² has been characterized as an important second messenger that affects a range of physiological and behavioral traits in an assortment of bacterial species. C-di-GMP was initially identified as an allosteric activator of cellulose synthase in Gluconacetobacter xylinum (1). Similarly, c-di-GMP has been implicated in regulation of cellulose biosynthesis and biofilm formation in the Gram-negative enteric pathogen Salmonella enterica serovar Typhimurium (2), as well as in survival of S. typhimurium in mice (3). Regulation of multicellular behaviors such as biofilms is not limited to Gram-negative bacteria, since there is evidence that c-di-GMP inhibits biofilm formation in Staphylococcus aureus as well (4). In addition, c-di-GMP was shown to regulate the transition between sessile and motile phenotypes in S. typhimurium, the opportunistic pathogen Pseudomonas aeruginosa, and commensal Escherichia coli (5).

In the classical biotype of the facultative intestinal pathogen Vibrio cholerae, not only does the c-di-GMP control biofilm formation (6), but it also affects expression of virulence factors such as cholera toxin (CT) (7). Specifically, increased intracellular concentrations of c-di-GMP favor biofilm formation by activating expression of Vibrio exopolysaccharide (vps) genes (6), which encode enzymes that produce the extracellular matrix that provides the infrastructure for the characteristic three-dimensional shape of biofilms. Decreased levels of c-di-GMP, on the other hand, are associated with reduced vps expression and increased production of CT (6, 7). The mechanisms involved in c-di-GMP-mediated regulation of these phenotypes are entirely unknown.

The inverse regulation of environment-specific (biofilm) and infection-specific (virulence) genes is of particular interest because of the shift in gene expression that is central to the pathogenic V. cholerae life cycle. In endemic regions, V. cholerae is typically found in aquatic reservoirs, and there is evidence that it forms biofilms on abiotic surfaces, including the chitinous exoskeletons of zooplankton and phytoplankton (8–10). V. cholerae undergoes a shift in gene expression upon entry into the host; vps expression ceases (11), and expression of virulence genes is induced (12–16). Whereas much research has been dedicated to studying environmental forms, such as biofilms, and to elucidating mechanisms of virulence gene regulation, little is understood about the molecular mechanisms that control the shift from the environmental to virulent state of V. cholerae. The intracellular concentration of c-di-GMP and proteins that modulate c-di-GMP levels may be key determinants in the transition from the environmental biofilm state to the virulent state of V. cholerae.

Biosynthesis and degradation of c-di-GMP have been predicted to occur through the activities of diguanylate cyclases and phosphodiesterases, respectively. These activities have been attributed to proteins containing GGDEF and/or EAL domains (17, 18). The putative diguanylate cyclases contain a conserved domain with a Gly-Gly-Asp-Glu-Phe motif (GGDEF, also known as domain of unknown function 1, or DUF1) (18). The GGDEF domain has limited but significant homology to eukaryotic adenylate cyclases (19). Synthesis of c-di-GMP by GGDEF-containing enzymes involves the 3' to 5' linkage of two GTP molecules into a cyclic molecule with the release of two pyrophosphate groups (20). A number of GGDEF domain proteins have been demonstrated to have diguanylate cyclase activity in vitro (21).

The putative c-di-GMP phosphodiesterases contain a domain enriched in glutamic acid, alanine, and leucine (EAL; also the domain of unknown function 2, DUF2). The functions were initially assigned to the GGDEF and EAL domains based on the occurrence of these sequences in enzymes with the described activities. For example, in G. xylinum, in which c-di-GMP metabolism was first characterized, six genes were found that control the intracellular concentration of c-di-GMP, each containing a GGDEF and an EAL domain (18, 22). The phosphodiesterase activity attributed to the EAL domain is based on limited homology to eukaryotic nucleotide phosphodiesterases (reviewed in Ref. 23) and is predicted to result in the linearization of c-di-GMP to pGpG, a physiologically inactive dinucleotide; a second, presumably ubiquitous phosphodiesterase, PDE-B, would hydrolyze pGpG to two GMP molecules.

Genes encoding proteins with GGDEF and/or EAL domains are abundant in bacterial genomes, usually in combination with other regulatory or sensory domains. In V. cholerae, 22 open reading frames encode proteins with homology to the EAL module, and 40 encode GGDEF domain proteins. There is considerable overlap of these proteins, as 10 possess both domains. One particular EAL domain protein of interest, VieA, is a putative response regulator with a conserved N-terminal phosphoreceiver domain, an internal EAL domain, and a C-terminal helix-turn-helix DNA binding domain. Encoded in the vieSAB three-component signal transduction system operon, the vieA locus has been demonstrated to be required for virulence of V. cholerae in the infant mouse (24). A vieA mutant demonstrates decreased CT production and 10-fold attenuated virulence (7, 24). Moreover, deletion of vieA results in increased intracellular c-di-GMP, vps expression, and biofilm formation (6). Conversely, overexpression of VieA decreases c-di-GMP levels and vps expression (6). Mutation of the phosphoreceiver or DNA-binding domains of VieA does not affect these phenotypes, whereas mutation of the central EAL domain does (6, 24). Expression of VieA and subsequent c-di-GMP activity during infection may thus be a critical signal, mediated by the modulation of c-di-GMP concentrations, for V. cholerae to down-regulate environment-specific genes and increase production of virulence factors.

There is a large body of indirect evidence that proteins containing the EAL domain possess c-di-GMP phosphodiesterase activity. Recently, the EAL domain was demonstrated to possess phosphodiesterase activity on an unnatural substrate, but the specificity of the EAL domain for c-di-GMP was not addressed (25). In the present work, we show that the EAL domain protein VieA acts as a c-di-GMP phosphodiesterase in a purified system. In addition, we have characterized the enzymatic properties of VieA in terms of optimal reaction conditions, ion requirement, ion inhibition, and kinetics.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Strains and Growth Conditions—Strains used in this study are listed in TABLE ONE. V. cholerae were grown in LB broth containing 100 µg/ml streptomycin at 37 °C with aeration. E. coli were incubated in LB containing 50 µg/ml ampicillin or 10 µg/ml chloramphenicol, as appropriate, at 37 °C with aeration, except during induction of protein expression (see details below).

Purification of EAL Domain Proteins—Expression of His₆-tagged EAL proteins was induced in exponential growth phase bacteria with 0.5 mM isopropyl 1-thio--D-galactopyranoside at 30 °C with aeration. Bacteria were collected by centrifugation and resuspended in His₆ buffer consisting of 10 mM Tris, pH 8, 300 mM NaCl, 50 mM NaH₂PO₄, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride, and 2 mM imidazole. All subsequent steps were carried out at 4 °C. The suspensions were lysed by French press at 16,000 p.s.i. and then briefly sonicated to break up genomic DNA. The lysates were fractionated by centrifugation at 10,000 x g for 30 min. The soluble fraction (supernatant) was incubated with Ni²⁺-nitrilotriacetic acid-agarose resin (Qiagen) for 1 h with gentle rocking. Subsequently, the samples were applied to a 5-ml polypropylene column (Qiagen), and the resin was allowed to settle. After elution of the His₆ buffer, the column was washed twice with wash buffer (His₆ buffer, 40 mM imidazole). The His₆-tagged proteins were eluted from the column with elution buffer (His₆ buffer, 250 mM imidazole) and then dialyzed overnight in Slide-A-Lyzer 10,000 molecular weight cut-off dialysis cassettes (Pierce) against 75 mM Tris, pH 8, 250 mM NaCl, 25 mM KCl, 10 mM MgCl₂, 30% glycerol. The lysates, column washes, and elutions were analyzed by SDS-PAGE and Coomassie Brilliant Blue staining to assess protein purity. The concentrations of the purified protein samples were determined using the modified Lowry protein assay kit (Pierce). Dialyzed proteins were stored at -20 °C.

Synthesis of c-di-GMP Substrate—C-di-GMP substrate for the phosphodiesterase assays was synthesized enzymatically using the VCA0956 protein, which contains a GGDEF diguanylate cyclase domain. VCA0956 was amplified from AC61 genomic DNA with primers A0956F2 (5'-GCTCTAGATTTAGGATACATTTTTATGCATCATCATCATCATCATATGACAACTGAAGATTTCAAAA-3') and A0956R (5'-ACATGCATGCTTAGAGCGGCATGACTCGAT-3'). Primer A0956F2 introduced an XbaI restriction site (underlined), a ribosomal binding site (boldface type), and an N-terminal His₆ tag (italicized). Primer A0956R introduced an SphI site (underlined) after the stop codon. The PCR fragment was digested and ligated into the arabinose-inducible expression vector pBAD33 and transformed into E. coli DH5. Clones were confirmed by digestion and sequencing. Protein expression was induced in exponential phase cells using 0.2% L-arabinose. His₆-VCA0956 was purified by Ni²⁺-nitrilotriacetic acid affinity chromatography using methods similar to those described for purification of the EAL domain proteins, except the His₆ binding buffer contained 35 mM imidazole, and the His₆ wash buffer contained 50 mM imidazole.

Purified His₆-VCA0956 (60 ng/µl) was incubated 4 h to overnight at 23 °C with 3 µlof[-³²P]GTP (3000 Ci/mmol, 3.3 µM; PerkinElmer Life Sciences) in buffer containing 75 mM Tris, pH 8, 250 mM NaCl, 25 mM KCl, and 10 mM MgCl₂. When higher concentrations of c-di-GMP were desired, unlabeled GTP was included at 0.01 or 0.1 mM final concentrations. The reactions were treated with calf intestinal phosphatase (New England Biolabs) for 30 min to hydrolyze noncyclized phosphate groups. The c-di-GMP product was separated from proteins by centrifugation through an Ultrafree-MC 5000 molecular weight cut-off column (Centricon) for 45 min at 5000 x g. Reaction products were separated by thin layer chromatography using polyethyleneimine (PEI)-cellulose plates and 1.5 M KH₂PO₄, pH 3.65, buffer (1) and then analyzed by phosphorimagery and volume analysis using ImageQuant 1.2. The final concentration and yield of c-di-GMP were calculated based on the percentage incorporation of radiolabeled GTP into radiolabeled c-di-GMP. Products were stored at -20 °C.

Phosphodiesterase Assays—The standard phosphodiesterase assay involved incubating purified protein with 11 nM [³²P]c-di-GMP (no unlabeled c-di-GMP) for 30 min to 1 h at room temperature in 75 mM Tris, pH 8, 250 mM NaCl, 25 mM KCl, and 10 mM MgCl₂. A no enzyme negative control and a snake venom phosphodiesterase (SVPD; Amersham Biosciences, product number E20240Y) positive control were included in all assays. The reactions were stopped by spotting 0.5 µl of the reaction on PEI-cellulose and allowing it to air-dry. Nucleotides were separated by TLC in 1.5 M KH₂PO₄, pH 3.65, and visualized by phosphorimagery.

The following experiments were done to determine the optimum parameters for phosphodiesterase activity (1). To determine the optimal reaction temperature, a master mix of the above reaction was aliquoted (30 µl) and incubated in heat blocks at 4, 16, 23, 30, 37, 45, 52, 65, or 80 °C (2). For optimization of reaction pH, the pH of the standard buffer described above was adjusted with HCl or NaOH to pH 3.5–12 (3). The optimum Mg²⁺ concentration for VieA activity was determined using 75 mM Tris, pH 8, and 150 mM KCl; MgCl₂ was added to the reaction at 0–100 mM final concentrations (4). The optimal ionic strength for the reaction was determined by measuring activity in 75 mM Tris, pH 8, 25 mM MgCl₂, and 0–500 mM KCl. For each experiment, 0.5 µl were analyzed by TLC after 45 min. Experiments addressing the inhibitory effects of divalent cations were performed at 23 °C using 75 mM Tris, pH 8, 25 mM KCl, 25 mM MgCl₂, and 0.33 µM c-di-GMP and analyzed as described. For all experiments, the percentage hydrolysis of c-di-GMP was determined. All assays were performed in triplicate.

The requirement of VieA for divalent cations was evaluated by first chelating divalent cations from the protein and substrate preparations. Briefly, Chelex-100 was added to 100-µl aliquots of VieA or c-di-GMP at 10 mg of Chelex-100 per ml and incubated for 10 min at room temperature. The protein or substrate was then transferred to fresh Chelex-100; this was repeated for a total of five treatments. The final incubation was allowed to proceed for 1.5 h at room temperature. Chelated samples were stored at -20 °C. The protein samples were confirmed to lack phosphodiesterase activity by incubating with [³²P]c-di-GMP in reaction buffer lacking MgCl₂. Divalent cations from MgCl₂, CaCl₂, MnCl₂, and ZnCl₂ were reconstituted into 75 mM Tris, pH 8, reaction buffer at 50 mM final concentrations. VieA was incubated in the buffer for 1 min prior to the addition of substrate. Phosphodiesterase activity was assayed in reactions containing each divalent cation alone or in combination (equimolar concentrations) with Mg²⁺ for 1 h at room temperature, analyzed by TLC, and quantified as percentage hydrolysis of c-di-GMP.

VieA kinetics experiments were done using the determined optimized conditions of 75 mM Tris, pH 8, 25 mM KCl, 25 mM MgCl₂ at 23 °C. Measurements were done with independently purified protein preparations. Because substrate concentrations were limiting, VieA was diluted to yield linear initial reaction rates. For the data shown, 0.013 µg of protein was used. C-di-GMP was included in the reactions at a range of concentrations between 11 nM and 0.91 µM. At 30-s intervals, aliquots of the phosphodiesterase reactions were spotted on PEI-cellulose plates for TLC and densitometry analysis. Mol of c-di-GMP hydrolyzed at each time point were calculated based on the percentage of total c-di-GMP hydrolyzed. Initial velocities of the reactions were determined by calculating the slope of the linear part of the reaction. K_m and V_max values were calculated using the Michaelis-Menten equation and Lineweaver-Burk methods.

To address the substrate specificity of VieA, phosphodiesterase assays were performed as described for c-di-GMP, except 1 µg of VieA and 13 nM [³H]cGMP (MP Biomedicals) were used. The reactions were incubated at 23 °C for 30 min to 16 h, and then the products were analyzed by TLC using PEI-cellulose plates and development in a solvent consisting of 5:2 methanol, 1 M ammonium acetate (26). The dried plates were cut to separate the lanes of the individual samples and then divided into 40 sections 0f 0.5 cm each. Each section was placed in Ecoscint-A scintillation fluid (National Diagnostics), and counts were measured using a Beckman LS 5000TD counter. The presence of [³H]cGMP and [³H]GMP was determined by comparing the location of sections with radioactivity relative to the published R_F values of these molecules (26). A no enzyme negative control and SVPD-positive control were included in these experiments.

Purification of pGpG— c-di-GMP, synthesized and purified as described above, was used as substrate in a reaction with VieA, and nucleotides were separated by TLC. Spots corresponding to pGpG in the PEI-cellulose matrix were removed from the flexible backing of the TLC plate. pGpG was extracted from the material twice by resuspending in 0.5 M (NH₄)₂CO₃ (1) and vortexing vigorously to solubilize the nucleotides. After a 15-min incubation at 23 °C, the supernatant containing pGpG was collected and centrifuged to remove any remaining PEI-cellulose debris.

VieA-His₆, VieAE170A-His₆, and mock-purified protein from the vector control were tested for the ability to degrade pGpG to GMP in phosphodiesterase assays set up as described above, except pGpG was substituted for c-di-GMP. Reaction products were analyzed by TLC.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
Detection of c-di-GMP Phosphodiesterase Activity by VieA—His₆-tagged VieA and VieAE170A, which contains a point mutation in the putative magnesium coordination site, were expressed and purified in E. coli DH5 to greater than 95% purity as determined by SDS-PAGE and Coomassie staining (Fig. 1A). These preparations, as well as that from the vector control processed in parallel, were tested for the ability to hydrolyze ³²P-labeled c-di-GMP. Substrate and products were detected using TLC and phosphorimagery (1). All R_F values for nucleotide species detected in these assays agreed with those identified previously (1). The SVPD control rapidly hydrolyzed c-di-GMP (R_F = 0.27) to GMP (R_F = 0.61). It was apparent that the VieA preparation was capable of degrading c-di-GMP due to the disappearance of the spot at R_F = 0.27 (Fig. 1B). Interestingly, the hydrolytic products present in the VieA reaction included pGpG (R_F = 0.55) as well as GMP (R_F = 0.61). The appearance of GMP as a product of VieA activity is addressed below. Furthermore, whereas SVPD was able to hydrolyze cGMP, VieA was not, indicating that VieA phosphodiesterase activity was specific to c-diGMP (data not shown).

The highly conserved Glu residue of the EAL motif, Glu¹⁷⁰, was predicted to be part of the coordination site for a divalent cation, specifically Mg²⁺ (23). Previous studies by our laboratory showed that mutation of conserved Glu¹⁷⁰ to Ala abolished the ability of VieA to repress vps expression; the same effect was seen with deletion of vieA and had the downstream effect of increasing biofilm formation (6). This phenotype was attributed to an increase in intracellular c-di-GMP due to mutation of the putative EAL PDE. Our studies confirmed that the VieAE170A protein is unable to hydrolyze c-di-GMP (Fig. 1B).

Activation and Inhibition of VieA Activity by Divalent Cations—Ross et al. characterized c-di-GMP phosphodiesterase activity in cellulose synthase-containing membranes of G. xylinum (1). This activity was stimulated by the addition of 10 mM Mg²⁺ to the membrane extracts and strongly inhibited by the presence of 2 mM Ca²⁺. Based on these data, the effect of these divalent cations, as well as Mn²⁺ and Zn²⁺, on VieA phosphodiesterase activity was investigated.

Aliquots of VieA and [³²P]c-di-GMP substrate were treated with Chelex-100 to remove divalent cations present in the storage buffers until no phosphodiesterase activity was evident (Fig. 2, lane 4). The reactions were reconstituted with Mg²⁺, Mn²⁺, Zn²⁺, or Ca²⁺ individually or in combination. Mg²⁺ was able to restore phosphodiesterase activity to VieA, although not to the level present in non-Chelex-treated protein (Fig. 2, lane 3 versus lane 5). This is possibly due to degradation of the protein during Chelex-100 treatment at room temperature. Alternatively, chelation of Mg²⁺ may have yielded a fraction of VieA in which proper folding could not be restored upon reintroduction of Mg²⁺. Mn²⁺ could restore phosphodiesterase activity to 55% of that seen with Mg²⁺. Neither Zn²⁺ nor Ca²⁺ permitted detectable hydrolysis of c-di-GMP in these assays. Interestingly, the addition of these cations in equimolar amounts as Mg²⁺ abolished VieA activity, suggesting an inhibitory role for Zn²⁺ and Ca²⁺. Furthermore, providing equimolar amounts of Mn²⁺ and Mg²⁺ to the reaction gave activity similar to providing Mn²⁺ alone (57% activity). These results suggest that Mn²⁺, Ca²⁺, and Zn²⁺ may have higher affinity than Mg²⁺ for the VieA metal coordination site.

View larger version (19K): [in this window] [in a new window]   FIGURE 1. Protein expression and detection of enzyme activity. His6-tagged VieA and VieAE170A were purified using Ni2+-nitrilotriacetic acid column chromatography and tested for the ability to hydrolyze enzymatically synthesized, radiolabeled c-di-GMP substrate. A, purity of VieA and VieAE170A protein preparations as determined by SDS-PAGE analysis and Coomassie staining. His6-tagged VieA and VieAE170A are 66 kDa. B, VieA (1 µg), VieAE170A (5 µg), and controls were incubated with [32P]c-di-GMP, and then reaction products were analyzed by TLC. VieA, but not VieAE170A or the vector control, demonstrated c-di-GMP phosphodiesterase activity. Lane 1, no enzyme control; lane 2, SVPD; lane 3, VieA; lane 4, VieAE170A; lane 5, vector control. Products of the reactions are labeled on the right. Cyclic diguanylate (c-di-GMP) migrated at RF = 0.27; pGpG migrated at RF = 0.55; and GMP migrated at RF = 0.61.

View larger version (39K): [in this window] [in a new window]   FIGURE 2. Divalent cation requirement of VieA. Divalent cations were removed from the VieA preparation by treatment with Chelex-100 until no activity was detected (lane A4). To determine which cations could support VieA phosphodiesterase activity, the protein was reconstituted with Mg2+, Mn2+, Zn2+, and Ca2+ individually or in combination with Mg2+, each at a concentration of 50 mM, and then tested for the ability to hydrolyze c-di-GMP. Mg2+ and, to a lesser extent, Mn2+ could restore VieA phosphodiesterase activity (lanes 5 and 6). Ca2+ and Zn2+ not only failed to reinstate activity (lanes 7 and 8) but also abolished c-di-GMP hydrolysis by VieA in the presence of equimolar concentrations of Mg2+ (lanes 10 and 11).

Optimization of VieA Reaction Conditions—The parameters for the VieA phosphodiesterase reaction were optimized for temperature, pH, and ionic strength (Fig. 3, A–C). For determination of optimal temperature, VieA activity was analyzed at temperatures ranging from 4 to 80 °C. VieA activity was significantly impaired at 52 °C and above, and no phosphodiesterase activity was apparent at 65 °C or above (not shown). Reaction rates were best and comparable at 23 and 30 °C after a 45-min incubation, suggesting that VieA phosphodiesterase is most active at ambient temperatures; subsequently, all reactions were incubated at 23 °C.

View larger version (16K): [in this window] [in a new window]   FIGURE 3. Optimization of VieA reaction conditions. A, the VieA phosphodiesterase reaction was performed at a range of temperatures from 4 to 80 °C. The highest rate of c-di-GMP hydrolysis was achieved at 23 and 30 °C. No activity was detectable at temperatures above 52 °C, but some c-di-GMP hydrolysis occurred at low temperatures. B, the pH of the phosphodiesterase reaction was adjusted to 3.5–12 prior to the addition of enzyme and substrate. VieA activity was comparable at pH between 5 and 9 and was inhibited at extreme basic or acidic pH. C, the ionic strength was adjusted upwards from the standard reaction buffer by the addition of 0–500 mM KCl. VieA activity was essentially the same with up to 50 mM added KCl; the total ionic strength of the reaction buffer is physiologically relevant. Further increases in ionic strength inhibited VieA phosphodiesterase activity, but only slightly. A–C, the data shown represent the mean percentage of substrate that was hydrolyzed in three independent experiments.

View larger version (20K): [in this window] [in a new window]   FIGURE 4. Hydrolysis of pGpG. The potential presence of contaminants with PDE-B activity in the protein preparations was addressed by incubating VieA, VieAE170, and vector control samples with radiolabeled pGpG as the substrate. Whereas SVPD could hydrolyze pGpG (RF = 0.55) to GMP (RF = 0.61), no other reaction showed GMP product after 24 h, verifying that no PDE-B contaminant was present.

Kinetics of VieA c-di-GMP Phosphodiesterase Activity—The optimal reaction conditions determined above were used to analyze the kinetics of VieA c-di-GMP hydrolytic activity. VieA phosphodiesterase activity demonstrated standard Michaelis-Menten kinetics. K_m and V_max values were determined for VieA using two independently expressed and purified preparations of enzyme. The K_m and V_max calculated for each protein preparation were very similar. VieA demonstrated a K_m of 0.06 µM, suggesting high affinity of VieA for c-di-GMP. V_max was determined to be 20.5 µmol min^-1 mg^-1 protein.

Phosphodiesterase B Activity of VieA—It has been suggested that a phosphodiesterase different from the EAL domain phosphodiesterase, PDE-B, hydrolyzes pGpG to GMP (27). Our experiments with VieA showed that GMP appeared only when higher concentrations of protein were used (data not shown). This introduced the possibility that a second phosphodiesterase was present in the VieA preparations. To address whether the appearance of GMP was due to a PDE-B contaminant, VieA, VieAE170A, and vector controls were used in phosphodiesterase assays using purified pGpG as substrate. Whereas SVPD was able to hydrolyze pGpG to GMP, neither VieA, VieAE170A, nor the vector control reactions showed GMP product after a 2-h incubation (Fig. 4). Even after 24 h, only a trace amount of GMP (<3%) was apparent in these reactions, compared with <1% for the c-di-GMP only control. Thus, if small quantities of a PDE-B are present, they are not responsible for the substantial amount of GMP that appears after a 45-min incubation of VieA with c-di-GMP. Because VieA was unable to hydrolyze pGpG to GMP when given pGpG as a substrate, it is possible that VieA can hydrolyze pGpG to GMP at a low rate when bound as an intermediate during c-di-GMP hydrolysis but cannot bind pGpG when introduced exogenously.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 
There has been increasing interest in the novel second messenger c-di-GMP and in its effect on bacterial gene regulation. A role for c-di-GMP has been demonstrated in regulation of exopolysaccharide biosynthesis, motility, and virulence in a variety of bacteria, both Gramnegative and Gram-positive (1–5, 25). With the exception of cellulose biosynthesis in G. xylinum and A. tumefaciens, in which c-di-GMP functions as an allosteric activator of cellulose synthase (1, 17), the mechanism by which c-di-GMP modulates these phenotypes is unknown. However, there has been significant progress in understanding the metabolism of c-di-GMP. Genetic studies of genes encoding the GGDEF domain, which possesses weak homology to eukaryotic adenylate cyclases, provided evidence that the GGDEF domain functions as a c-di-GMP cyclase (17). Recently, GGDEF proteins from bacteria representing the major phylogenetic branches were purified and demonstrated to have diguanylate cyclase activity in vitro (21).

Similar to the GGDEF domain, the assignment of c-di-GMP hydrolytic activity was initially ascribed to the EAL domain based on genetic evidence (5, 6, 18). For example, mutation of the EAL-encoding gene vieA resulted in increased levels of c-di-GMP in nucleotide extracts (6). This work demonstrates c-di-GMP hydrolytic activity by the EAL-containing protein VieA. VieA was selected as the EAL protein of interest because of its role in regulation of vps expression and biofilm formation, and in CT expression and virulence of V. cholerae, a facultative intestinal pathogen. Furthermore, previous work investigating EAL domain function could not specifically attribute c-diGMP phosphodiesterase activity to the EAL domain, because the GGDEF domain was present in these proteins as well or because the protein contained both domains but showed primarily diguanylate cyclase activity (18). VieA lacks a GGDEF domain, which allows unambiguous assignment of c-diGMP phosphodiesterase activity to the EAL domain.

Using enzymatically synthesized c-di-GMP substrate, VieA was demonstrated to possess c-di-GMP hydrolytic activity. Protein preparations of vector alone, processed in parallel, demonstrated no activity. The conserved Glu residue (Glu¹⁷⁰) in the EAL domain, which was predicted to be a divalent ion coordination site and probably required for EAL activity (23), was confirmed to be necessary for VieA activity, since an E170A mutation abolished c-di-GMP phosphodiesterase activity of the protein. The measured K_m of VieA for c-di-GMP was calculated to be 0.06 µM. This K_m is considerably lower than that of other bacterial cyclic nucleotide phosphodiesterases. For example, CpdA, a cAMP phosphodiesterase of E. coli, has a K_m of 0.5 mM cAMP (28). A Vibrio fischeri zinc-containing cyclic nucleotide phosphodiesterase showed a lower K_m of 73 µM cAMP (29). The measured K_m for VieA is also 4-fold lower than the K_m measured for phosphodiesterase-containing membranes of G. xylinum, 0.25 µM (27), suggesting high affinity of VieA for this substrate.

The VieA EAL domain protein appears to be specific for the c-di-GMP substrate. Whereas SVPD is a promiscuous phosphodiesterase that can hydrolyze among others c-di-GMP, pGpG, cGMP, and cAMP, c-di-GMP was the only substrate tested that could be hydrolyzed by VieA. Previous studies by Ross et al. (27) addressed the ability of phosphodiesterase-containing membranes to hydrolyze cGMP and c-di-GMP analogues, including c-di-IMP, c-di-AMP, c-di-CMP, and diastereoisomers of c-di-GMP, so the latter were not considered in this work.

Ross et al. (27) predicted that EAL phosphodiesterases function solely in the first step of c-di-GMP hydrolysis to yield pGpG and that a second enzyme, PDE-B, degrades pGpG to GMP. Analysis of the VieA reaction products by TLC showed that not only was the linear pGpG product formed, but GMP was produced as well. Because GMP was detectable only in reactions containing 10–100-fold higher concentration of protein than was used in the kinetics studies, the possibility arose that a PDE-B was present as a contaminant in the protein preparation. However, direct testing of VieA, VieAE170A, and the vector control for the ability to hydrolyze pGpG as a substrate failed to detect a PDE-B. This was not due to a defect in the purification of pGpG, since the SVPD-positive control was able to hydrolyze pGpG to GMP, implying that PDE-B activity detected in these assays can be ascribed to VieA. Because the rate of GMP formation was orders of magnitude slower than that of pGpG, the PDE-B activity of VieA is probably not physiologically significant.

An intriguing result of this assay was that GMP product was not formed in the VieA reaction when pGpG was provided exogenously as the substrate. It is possible that VieA does not bind exogenous pGpG efficiently and that GMP is only produced when pGpG is already bound, immediately following the initial hydrolysis of c-di-GMP. Preliminary binding studies investigating the ability of VieA to bind c-di-GMP and pGpG support the hypothesis that VieA has very low affinity for pGpG relative to c-di-GMP (data not shown). Alternatively, because VieA also is predicted to be a response regulator, which often bind DNA as dimers to control transcription (30–32), it is possible that dimerization of VieA also affects its enzyme activity, specifically in mediating hydrolysis of the pGpG intermediate product. It is unlikely that VieA dimerization is required for the initial hydrolytic cleavage of c-di-GMP, since the conserved response regulator domains can be deleted from VieA without affecting its regulatory activity on vps expression (6). Determination of the crystal structure of VieA may elucidate the potential overlap between the presumed regulatory function of VieA and its enzymatic activity.

As a potential dual function protein, VieA phosphodiesterase and response regulator activities may be affected by phosphorylation. Phosphorylation of response regulators of two- and three-component regulatory systems typically increases affinity of the protein for its target promoter DNA and thus increases expression of that gene. Phosphorylation of VieA may positively or negatively affect its enzyme activity as well. Preliminary studies with VieA phosphorylated in vitro with acetyl phosphate suggest that there is no significant change in the rate of VieA hydrolysis of c-di-GMP (data not shown). In addition, deletion of the VieA phosphoreceiver domain, as stated above, or mutation of the conserved aspartic acid residue that is predicted to be the site of phosphorylation of VieA had no effect on the ability of the VieA EAL domain to repress expression of vps genes (6). Thus, we do not expect phosphorylation to affect the phosphodiesterase activity of VieA.

VieA was determined to have optimal activity at neutral pH, physiological ionic strength, and ambient temperatures. The in vitro optimum conditions with respect to pH and ionic strength coincided with those expected to be experienced by VieA in the bacterial cytoplasm. The temperature optimum is consistent with the facultative pathogen nature of V. cholerae, which includes growth in the human small intestine at 37 °C and growth in aqueous reservoirs in temperate zones around the world. V. cholerae encodes 21 additional EAL domain proteins and 41 GGDEF proteins (10 of these have both domains) (23), each of which could potentially affect the intracellular pools of c-diGMP. Interestingly, like VieA, other GGDEF and EAL proteins often contain sensory/regulatory modules that could participate in signal transduction. This introduces the likelihood that subsets of GGDEF and/or EAL domain proteins are expressed under specific conditions. The vieSAB locus, for example, is expressed at low levels during growth in LB broth in vitro but is induced during infection of the mouse as well as during growth in minimal medium supplemented with the amino acids Asn, Arg, Glu, and Ser (6, 33, 34). Other GGDEF and EAL proteins may dominate under other, as yet undefined conditions.

Strong inhibition of VieA c-diGMP phosphodiesterase activity by Ca²⁺ was observed in these studies, supporting earlier findings using phosphodiesterase-containing membrane preparations (1). In fact, Ca²⁺ and Zn²⁺ inhibited activity even when VieA was preincubated with MgCl₂, so VieA presumably was saturated with Mg²⁺, suggesting that Ca²⁺ is capable of displacing Mg²⁺ from the metal coordination site. These findings may be important for understanding the function of proteins in which both GGDEF diguanylate cyclases and EAL phosphodiesterase domains are present. In such proteins with domains of opposing functions, regulation of the individual domains is likely to be critical, and Ca²⁺ may provide a means by which c-di-GMP hydrolysis can be inhibited. In this model, the presence of Ca²⁺ would repress c-di-GMP hydrolysis, allowing c-di-GMP to accumulate through the activity of GGDEF activity. Regulation of GGDEF activity by divalent cations has not been described.

Ca²⁺ inhibition of c-di-GMP degradation by EAL domain proteins has particularly interesting implications with regard to V. cholerae biofilm formation. Formation of most V. cholerae biofilms is dependent on the production of exopolysaccharide (VPS) (35). However, VPS-independent biofilms that form in seawater have been described (36, 37). These biofilms have an altered architecture and cell-cell interaction that appear to be mediated by contacts between the lipopolysaccharide O-antigen of adjacent bacteria and are dependent on the presence of Ca²⁺ in the growth medium. Previous studies by our laboratory have demonstrated that mutation of an EAL can cause increased intracellular c-di-GMP and increased VPS-dependent biofilm formation. Similarly, inhibition of EAL activity by Ca²⁺ may positively regulate VPS-independent biofilm development as well. Because biofilm formation is thought to promote survival of V. cholerae in the environment, and because biofilm-associated V. cholerae are predicted to be more infectious due to protection from a variety of antimicrobial agents, regulation of c-di-GMP metabolism by Ca²⁺ may be important to V. cholerae fitness in certain environments.

The bacterial second messenger c-di-GMP is being implicated in a wide variety of bacterial phenotypes, especially multicellular behaviors such as biofilms. In addition, there is evidence in V. cholerae and S. typhimurium that c-di-GMP can regulate virulence phenotypes as well. C-di-GMP may be a more global regulator of bacterial gene and protein regulation than is realized, so it is critical that we understand the metabolism of this compound. These experiments provide the first direct evidence that an EAL domain protein, VieA, possesses c-di-GMP hydrolytic activity in a purified system. Moreover, Ca²⁺ inhibition may provide a means of regulating EAL-mediated degradation of c-di-GMP.

	FOOTNOTES

 
^* This work was supported by National Institutes of Health Grant AI45746 (to A. C.) and Center for Gastroenterology Research on Absorptive and Secretory Processes, New England Medical Center, Grant P30DK34928. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom correspondence should be addressed: Dept. of Molecular Biology and Microbiology, Tufts University, 136 Harrison Ave., Boston, MA 02111. Tel.: 617-636-2144; Fax: 617-636-2175; E-mail: Andrew.camilli{at}tufts.edu.

² The abbreviations used are: c-di-GMP, 3',5'-cyclic diguanylic acid; CT, cholera toxin; PEI, polyethyleneimine; SVPD, snake venom phosphodiesterase; PDE, phosphodiesterase.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

 

1. Ross, P., Aloni, Y., Weinhouse, H., Michaeli, D., Weinberger-Ohana, P., Mayer, R., and M. Benziman. (1986) Carbohydr. Res. 149, 101-117[CrossRef]
2. Garcia, B., Latasa, C., Solano, C., Garcia-del Portillo, F., Gamazo, C., and Lasa, I. (2004) Mol. Microbiol. 54, 264-277[CrossRef][Medline] [Order article via Infotrieve]
3. Hisert, K. B., MacCoss, M., Shiloh, M. U., Darwin, K. H., Singh, S., Jones, R. A., Ehrt, S., Zhang, Z., Gaffney, B. L., Gandotra, S., Holden, D. W., Murray, D., and Nathan, C. (2005) Mol. Microbiol. 56, 1234-1245[CrossRef][Medline] [Order article via Infotrieve]
4. Karaolis, D. K., Rashid, M. H., Chythanya, R., Luo, W., Hyodo, M., and Hayakawa, Y. (2005) Antimicrob. Agents Chemother. 49, 1029-1038[Abstract/Free Full Text]
5. Simm, R., Morr, M., Kader, A., Nimtz, M., and Romling, U. (2004) Mol. Microbiol. 53, 1123-1134[CrossRef][Medline] [Order article via Infotrieve]
6. Tischler, A. D., and Camilli, A. (2004) Mol. Microbiol. 53, 857-869[CrossRef][Medline] [Order article via Infotrieve]
7. Tischler, A. D., Lee, S. H., and Camilli, A. (2002) J. Bacteriol. 184, 4104-4113[Abstract/Free Full Text]
8. Huq, A., Small, E. B., West, P. A., Huq, M. I., Rahman, R., and Colwell, R. R. (1983) Appl. Environ. Microbiol. 45, 275-283[Abstract/Free Full Text]
9. Tamplin, M. L., Gauzens, A. L., Huq, A., Sack, D. A., and Colwell, R. R. (1990) Appl. Environ. Microbiol. 56, 1977-1980[Abstract/Free Full Text]
10. Watnick, P. I., and Kolter, R. (1999) Mol. Microbiol. 34, 586-595[CrossRef][Medline] [Order article via Infotrieve]
11. Schoolnik, G. K., Voskuil, M. I., Schnappinger, D., Yildiz, F. H., Meibom, K., Dolganov, N. A., Wilson, M. A., and Chong, K. H. (2001) Methods. Enzymol. 336, 3-18[Medline] [Order article via Infotrieve]
12. Herrington, D. A., Hall, R. H., Losonsky, G., Mekalanos, J. J., Taylor, R. K., and Levine, M. M. (1988) J. Exp. Med. 168, 1487-1492[Abstract/Free Full Text]
13. Lee, S. H., Hava, D. L., Waldor, M. K., and Camilli, A. (1999) Cell 99, 625-634[CrossRef][Medline] [Order article via Infotrieve]
14. Lee, S. H., Butler, S. M., and Camilli, A. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 6889-6894[Abstract/Free Full Text]
15. Miller, V. L., and Mekalanos, J. J. (1985) J. Bacteriol. 163, 580-585[Abstract/Free Full Text]
16. Taylor, R. K., Miller, V. L., Furlong, D. B., and Mekalanos, J. J. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 2833-2837[Abstract/Free Full Text]
17. Ausmees, N., Mayer, R., Weinhouse, H., Volman, G., Amikam, D., Benziman, M., and Lindberg, M. (2001) FEMS Microbiol. Lett. 204, 163-167[CrossRef][Medline] [Order article via Infotrieve]
18. Tal, R., Wong, H. C., Calhoon, R., Gelfand, D., Fear, A. L., Volman, G., Mayer, R., Ross, P., Amikam, D., Weinhouse, H., Cohen, A., Sapir, S., Ohana, P., and Benziman, M. (1998) J. Bacteriol. 180, 4416-4425[Abstract/Free Full Text]
19. Pei, J., and Grishin, N. V. (2001) Proteins 42, 210-216[CrossRef][Medline] [Order article via Infotrieve]
20. Chan, C., Paul, R., Samoray, D., Amiot, N. C., Giese, B., Jenal, U., and Schirmer, T. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 17084-17089[Abstract/Free Full Text]
21. Ryjenkov, D. A., Tarutina, M., Moskvin, O. V., and Gomelsky, M. (2005) J. Bacteriol 187, 1792-1798[Abstract/Free Full Text]
22. Wong, H. C., Fear, A. L., Calhoon, R. D., Eichinger, G. H., Mayer, R., Amikam, D., Benziman, M., Gelfand, D. H., Meade, J. H., and Emerick, A. W. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 8130-8134[Abstract/Free Full Text]
23. Galperin, M. Y., Nikolskaya, A. N., and Koonin, E. V. (2001) FEMS Microbiol. Lett. 203, 11-21[CrossRef][Medline] [Order article via Infotrieve]
24. Tischler, A. D. a. A. C. (2005) Infect. Immun. In press
25. Bobrov, A. G., Kirillina, O., and Perry, R. D. (2005) FEMS Microbiol. Lett.
26. Keirns, J. J., Wheeler, M. A., and Bitensky, M. W. (1974) Anal. Biochem. 61, 336-348[CrossRef][Medline] [Order article via Infotrieve]
27. Ross, P., Mayer, R., Weinhouse, H., Amikam, D., Huggirat, Y., Benziman, M., de Vroom, E., Fidder, A., de Paus, P., and Sliedregt, L. A. (1990) J. Biol. Chem. 265, 18933-18943[Abstract/Free Full Text]
28. Imamura, R., Yamanaka, K., Ogura, T., Hiraga, S., Fujita, N., Ishihama, A., and Niki, H. (1996) J. Biol. Chem. 271, 25423-25429[Abstract/Free Full Text]
29. Callahan, S. M., Cornell, N. W., and Dunlap, P. V. (1995) J. Biol. Chem. 270, 17627-17632[Abstract/Free Full Text]
30. Dziejman, M., and Mekalanos, J. J. (1994) Mol. Microbiol. 13, 485-494[Medline] [Order article via Infotrieve]
31. Hidaka, Y., Park, H., and Inouye, M. (1997) FEBS Lett. 400, 238-242[CrossRef][Medline] [Order article via Infotrieve]
32. Scarlato, V., and Rappuoli, R. (1991) J. Bacteriol. 173, 7401-7404[Abstract/Free Full Text]
33. Camilli, A., and Mekalanos, J. J. (1995) Mol. Microbiol. 18, 671-683[CrossRef][Medline] [Order article via Infotrieve]
34. Lee, S. H., Angelichio, M. J., Mekalanos, J. J., and Camilli, A. (1998) J. Bacteriol. 180, 2298-2305[Abstract/Free Full Text]
35. Yildiz, F. H., and Schoolnik, G. K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4028-4033[Abstract/Free Full Text]
36. Kierek, K., and Watnick, P. I. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 14357-14362[Abstract/Free Full Text]
37. Kierek, K., and Watnick, P. I. (2003) Appl. Environ. Microbiol. 69, 5079-5088[Abstract/Free Full Text]
38. Yildiz, F. H., and Schoolnik, G. K. (1998) J. Bacteriol. 180, 773-784[Abstract/Free Full Text]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				E. Karatan and P. Watnick Signals, Regulatory Networks, and Materials That Build and Break Bacterial Biofilms Microbiol. Mol. Biol. Rev., June 1, 2009; 73(2): 310 - 347. [Abstract] [Full Text] [PDF]

				C. Solano, B. Garcia, C. Latasa, A. Toledo-Arana, V. Zorraquino, J. Valle, J. Casals, E. Pedroso, and I. Lasa Genetic reductionist approach for dissecting individual roles of GGDEF proteins within the c-di-GMP signaling network in Salmonella PNAS, May 12, 2009; 106(19): 7997 - 8002. [Abstract] [Full Text] [PDF]

				G. Minasov, S. Padavattan, L. Shuvalova, J. S. Brunzelle, D. J. Miller, A. Basle, C. Massa, F. R. Collart, T. Schirmer, and W. F. Anderson Crystal Structures of YkuI and Its Complex with Second Messenger Cyclic Di-GMP Suggest Catalytic Mechanism of Phosphodiester Bond Cleavage by EAL Domains J. Biol. Chem., May 8, 2009; 284(19): 13174 - 13184. [Abstract] [Full Text] [PDF]

				N. Sommerfeldt, A. Possling, G. Becker, C. Pesavento, N. Tschowri, and R. Hengge Gene expression patterns and differential input into curli fimbriae regulation of all GGDEF/EAL domain proteins in Escherichia coli Microbiology, April 1, 2009; 155(4): 1318 - 1331. [Abstract] [Full Text] [PDF]

				B. K. Hammer and B. L. Bassler Distinct Sensory Pathways in Vibrio cholerae El Tor and Classical Biotypes Modulate Cyclic Dimeric GMP Levels To Control Biofilm Formation J. Bacteriol., January 1, 2009; 191(1): 169 - 177. [Abstract] [Full Text] [PDF]

				M. Kumar and D. Chatterji Cyclic di-GMP: a second messenger required for long-term survival, but not for biofilm formation, in Mycobacterium smegmatis Microbiology, October 1, 2008; 154(10): 2942 - 2955. [Abstract] [Full Text] [PDF]

				H. F. Martinez-Wilson, R. Tamayo, A. D. Tischler, D. W. Lazinski, and A. Camilli The Vibrio cholerae Hybrid Sensor Kinase VieS Contributes to Motility and Biofilm Regulation by Altering the Cyclic Diguanylate Level J. Bacteriol., October 1, 2008; 190(19): 6439 - 6447. [Abstract] [Full Text] [PDF]

				N. Sudarsan, E. R. Lee, Z. Weinberg, R. H. Moy, J. N. Kim, K. H. Link, and R. R. Breaker Riboswitches in Eubacteria Sense the Second Messenger Cyclic Di-GMP Science, July 18, 2008; 321(5887): 411 - 413. [Abstract] [Full Text] [PDF]

				D. A. Rosen, J. S. Pinkner, J. M. Jones, J. N. Walker, S. Clegg, and S. J. Hultgren Utilization of an Intracellular Bacterial Community Pathway in Klebsiella pneumoniae Urinary Tract Infection and the Effects of FimK on Type 1 Pilus Expression Infect. Immun., July 1, 2008; 76(7): 3337 - 3345. [Abstract] [Full Text] [PDF]

				F. Rao, Y. Yang, Y. Qi, and Z.-X. Liang Catalytic Mechanism of Cyclic Di-GMP-Specific Phosphodiesterase: a Study of the EAL Domain-Containing RocR from Pseudomonas aeruginosa J. Bacteriol., May 15, 2008; 190(10): 3622 - 3631. [Abstract] [Full Text] [PDF]

				R. Tamayo, S. Schild, J. T. Pratt, and A. Camilli Role of Cyclic Di-GMP during El Tor Biotype Vibrio cholerae Infection: Characterization of the In Vivo-Induced Cyclic Di-GMP Phosphodiesterase CdpA Infect. Immun., April 1, 2008; 76(4): 1617 - 1627. [Abstract] [Full Text] [PDF]

				R. B. R. Ferreira, L. C. M. Antunes, E. P. Greenberg, and L. L. McCarter Vibrio parahaemolyticus ScrC Modulates Cyclic Dimeric GMP Regulation of Gene Expression Relevant to Growth on Surfaces J. Bacteriol., February 1, 2008; 190(3): 851 - 860. [Abstract] [Full Text] [PDF]

				M. Nagata, C. Kaito, and K. Sekimizu Phosphodiesterase Activity of CvfA Is Required for Virulence in Staphylococcus aureus J. Biol. Chem., January 25, 2008; 283(4): 2176 - 2184. [Abstract] [Full Text] [PDF]

				A. J. Wolfe and K. L. Visick Get the Message Out: Cyclic-Di-GMP Regulates Multiple Levels of Flagellum-Based Motility J. Bacteriol., January 15, 2008; 190(2): 463 - 475. [Full Text] [PDF]

				J. S. Matson, J. H. Withey, and V. J. DiRita Regulatory Networks Controlling Vibrio cholerae Virulence Gene Expression Infect. Immun., December 1, 2007; 75(12): 5542 - 5549. [Full Text] [PDF]

				L. Claret, S. Miquel, N. Vieille, D. A. Ryjenkov, M. Gomelsky, and A. Darfeuille-Michaud The Flagellar Sigma Factor FliA Regulates Adhesion and Invasion of Crohn Disease-associated Escherichia coli via a Cyclic Dimeric GMP-dependent Pathway J. Biol. Chem., November 16, 2007; 282(46): 33275 - 33283. [Abstract] [Full Text] [PDF]

				J. H. Merritt, K. M. Brothers, S. L. Kuchma, and G. A. O'Toole SadC Reciprocally Influences Biofilm Formation and Swarming Motility via Modulation of Exopolysaccharide Production and Flagellar Function J. Bacteriol., November 15, 2007; 189(22): 8154 - 8164. [Abstract] [Full Text] [PDF]

				S. L. Kuchma, K. M. Brothers, J. H. Merritt, N. T. Liberati, F. M. Ausubel, and G. A. O'Toole BifA, a Cyclic-Di-GMP Phosphodiesterase, Inversely Regulates Biofilm Formation and Swarming Motility by Pseudomonas aeruginosa PA14 J. Bacteriol., November 15, 2007; 189(22): 8165 - 8178. [Abstract] [Full Text] [PDF]

				P. C. Fineran, N. R. Williamson, K. S. Lilley, and G. P. C. Salmond Virulence and Prodigiosin Antibiotic Biosynthesis in Serratia Are Regulated Pleiotropically by the GGDEF/EAL Domain Protein, PigX J. Bacteriol., November 1, 2007; 189(21): 7653 - 7662. [Abstract] [Full Text] [PDF]

				A. Tanaka, H. Takahashi, and T. Shimizu Critical Role of the Heme Axial Ligand, Met95, in Locking Catalysis of the Phosphodiesterase from Escherichia coli (Ec DOS) toward Cyclic diGMP J. Biol. Chem., July 20, 2007; 282(29): 21301 - 21307. [Abstract] [Full Text] [PDF]

				J. Matsunaga, M. Lo, D. M. Bulach, R. L. Zuerner, B. Adler, and D. A. Haake Response of Leptospira interrogans to Physiologic Osmolarity: Relevance in Signaling the Environment-to-Host Transition Infect. Immun., June 1, 2007; 75(6): 2864 - 2874. [Abstract] [Full Text] [PDF]

				Y.-K. Kim and L. L. McCarter ScrG, a GGDEF-EAL Protein, Participates in Regulating Swarming and Sticking in Vibrio parahaemolyticus J. Bacteriol., June 1, 2007; 189(11): 4094 - 4107. [Abstract] [Full Text] [PDF]

				R. Simm, A. Lusch, A. Kader, M. Andersson, and U. Romling Role of EAL-Containing Proteins in Multicellular Behavior of Salmonella enterica Serovar Typhimurium J. Bacteriol., May 1, 2007; 189(9): 3613 - 3623. [Abstract] [Full Text] [PDF]

				J. T. Pratt, R. Tamayo, A. D. Tischler, and A. Camilli PilZ Domain Proteins Bind Cyclic Diguanylate and Regulate Diverse Processes in Vibrio cholerae J. Biol. Chem., April 27, 2007; 282(17): 12860 - 12870. [Abstract] [Full Text] [PDF]

				M. Christen, B. Christen, M. G. Allan, M. Folcher, P. Jeno, S. Grzesiek, and U. Jenal DgrA is a member of a new family of cyclic diguanosine monophosphate receptors and controls flagellar motor function in Caulobacter crescentus PNAS, March 6, 2007; 104(10): 4112 - 4117. [Abstract] [Full Text] [PDF]

				B. Lim, S. Beyhan, and F. H. Yildiz Regulation of Vibrio Polysaccharide Synthesis and Virulence Factor Production by CdgC, a GGDEF-EAL Domain Protein, in Vibrio cholerae J. Bacteriol., February 1, 2007; 189(3): 717 - 729. [Abstract] [Full Text] [PDF]

				R. P. Ryan, Y. Fouhy, J. F. Lucey, and J. M. Dow Cyclic Di-GMP Signaling in Bacteria: Recent Advances and New Puzzles J. Bacteriol., December 15, 2006; 188(24): 8327 - 8334. [Full Text] [PDF]

				T. M. O'Shea, A. H. Klein, K. Geszvain, A. J. Wolfe, and K. L. Visick Diguanylate Cyclases Control Magnesium-Dependent Motility of Vibrio fischeri J. Bacteriol., December 1, 2006; 188(23): 8196 - 8205. [Abstract] [Full Text] [PDF]

				B. Christen, M. Christen, R. Paul, F. Schmid, M. Folcher, P. Jenoe, M. Meuwly, and U. Jenal Allosteric Control of Cyclic di-GMP Signaling J. Biol. Chem., October 20, 2006; 281(42): 32015 - 32024. [Abstract] [Full Text] [PDF]

				K. Suzuki, P. Babitzke, S. R. Kushner, and T. Romeo Identification of a novel regulatory protein (CsrD) that targets the global regulatory RNAs CsrB and CsrC for degradation by RNase E Genes & Dev., September 15, 2006; 20(18): 2605 - 2617. [Abstract] [Full Text] [PDF]

				F. L. Thompson, K. E. Klose, and the AVIB Group Vibrio2005: the First International Conference on the Biology of Vibrios J. Bacteriol., July 1, 2006; 188(13): 4592 - 4596. [Full Text] [PDF]

				S. Beyhan, A. D. Tischler, A. Camilli, and F. H. Yildiz Differences in Gene Expression between the Classical and El Tor Biotypes of Vibrio cholerae O1. Infect. Immun., June 1, 2006; 74(6): 3633 - 3642. [Abstract] [Full Text] [PDF]

				B. M. Pruss, C. Besemann, A. Denton, and A. J. Wolfe A Complex Transcription Network Controls the Early Stages of Biofilm Development by Escherichia coli J. Bacteriol., June 1, 2006; 188(11): 3731 - 3739. [Full Text] [PDF]

				M. Y. Galperin Structural classification of bacterial response regulators: diversity of output domains and domain combinations. J. Bacteriol., June 1, 2006; 188(12): 4169 - 4182. [Abstract] [Full Text] [PDF]

				S. Beyhan, A. D. Tischler, A. Camilli, and F. H. Yildiz Transcriptome and Phenotypic Responses of Vibrio cholerae to Increased Cyclic di-GMP Level. J. Bacteriol., May 1, 2006; 188(10): 3600 - 3613. [Abstract] [Full Text] [PDF]

				M. M. Mendez-Ortiz, M. Hyodo, Y. Hayakawa, and J. Membrillo-Hernandez Genome-wide Transcriptional Profile of Escherichia coli in Response to High Levels of the Second Messenger 3',5'-Cyclic Diguanylic Acid J. Biol. Chem., March 24, 2006; 281(12): 8090 - 8099. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 280/39/33324    most recent M506500200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tamayo, R. Articles by Camilli, A. Search for Related Content PubMed PubMed Citation Articles by Tamayo, R. Articles by Camilli, A. Social Bookmarking                      What's this?